Dompé REP0211 – reparixin in pancreatic islet transplantation

• Research type

  Research Study

• Full title

  A phase 3, multicenter, randomized, double-blind, parallel assignment study to assess the efficacy and safety of reparixin in pancreatic islet transplantation

• IRAS ID

  105399

• Contact name

  James Shaw

• Sponsor organisation

  Dompé s.p.a.

• Eudract number

  2011-006201-10

• ISRCTN Number

  N/A

• Research summary

  The purpose of this study is to find out whether reparixin, added to the immun'suppressan's, improves the outcome of the transplanted pancreatic islets. The safety of reparixin in patients undergoing pancreatic islet transplantation will also be studied.

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  12/NE/0243

• Date of REC Opinion

  14 Sep 2012

• REC opinion

  Further Information Favourable Opinion